As a contract research and development organization, Zebrasci specializes in parenteral combination products and has helped clients commercialize over 30 such products in multiple geographies. The company provides consultative support in early feasibility testing through product verification/validation, and also supports incoming inspection, final product lot release testing, and market complaint root cause investigations. Zebrasci adheres to cGMP FDA regulations, ISO 17025, ISO 13485, and customer quality system requirements, and operates two locations with over 30,000 square feet of clean room, laboratory, and office space.